Mpl Baltimore: a Thrombopoietin Receptor Polymorphism Associated with Thrombocytosis

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2004 Jul 23

PMID 15269348

Citations 40

Authors

Alison R Moliterno

Donna M Williams

Laura I Gutierrez-Alamillo

Roberto Salvatori

Roxann G Ingersoll

Jerry L Spivak

Affiliations

Soon will be listed here.

Abstract

The chronic myeloproliferative disorders (MPD) are clonal hematopoietic stem cell disorders of unknown etiology. We have reported defective thrombopoietin receptor (Mpl) protein expression in MPD patients. To determine whether the basis of abnormal Mpl protein expression was due to mutations in the Mpl gene, we sequenced Mpl cDNA from MPD patients. We found a single nucleotide substitution (G1238T) that results in a change from lysine to asparagine at amino acid 39 (K39N) in three African-American women referred for an evaluation of an MPD. We subsequently screened more than 400 patients and controls and found that the K39N substitution is a polymorphism restricted to African Americans and that approximately 7% of African Americans are heterozygous for K39N. African Americans with the K39N polymorphism had a significantly higher platelet count than controls without the polymorphism (P < 0.001) and reduced platelet protein Mpl expression. Expression of an Mpl cDNA containing the K39N substitution in cell lines was associated with incomplete processing and a reduction in Mpl protein, recapitulating the Mpl protein defect observed in platelets from individuals with K39N. K39N represents an identified functional Mpl polymorphism and is associated with altered protein expression of Mpl and a clinical phenotype of thrombocytosis.

Citing Articles

Myeloproliferative Neoplasms: Challenging Dogma.

Spivak J J Clin Med. 2024; 13(22).

PMID: 39598101 PMC: 11595126. DOI: 10.3390/jcm13226957.

Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.

Molteni E, Bono E, Galli A, Elena C, Ferrari J, Fiorelli N Blood. 2023; 142(7):643-657.

PMID: 37216690 PMC: 10644067. DOI: 10.1182/blood.2022019304.

In and out: Traffic and dynamics of thrombopoietin receptor.

Roy A, Shrivastva S, Naseer S J Cell Mol Med. 2021; 25(19):9073-9083.

PMID: 34448528 PMC: 8500957. DOI: 10.1111/jcmm.16878.

The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN.

Spivak J, Moliterno A Front Oncol. 2021; 11:641613.

PMID: 33777803 PMC: 7987816. DOI: 10.3389/fonc.2021.641613.

Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management.

Stockklausner C, Duffert C, Cario H, Knofler R, Streif W, Kulozik A Ann Hematol. 2021; 100(7):1647-1665.

PMID: 33712866 PMC: 8195939. DOI: 10.1007/s00277-021-04485-0.

References

Miller K, Ming T, Schulze A, Withler R . Denaturing gradient gel electrophoresis (DGGE): a rapid and sensitive technique to screen nucleotide sequence variation in populations. Biotechniques. 1999; 27(5):1016-8, 1020-2, 1024 passim. DOI: 10.2144/99275rr02. View

Moliterno A, Spivak J . Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood. 1999; 94(8):2555-61. View

van den Oudenrijn S, Bruin M, Folman C, Peters M, Faulkner L, de Haas M . Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia. Br J Haematol. 2000; 110(2):441-8. DOI: 10.1046/j.1365-2141.2000.02175.x. View

Tonelli R, Scardovi A, Pession A, Strippoli P, Bonsi L, Vitale L . Compound heterozygosity for two different amino-acid substitution mutations in the thrombopoietin receptor (c-mpl gene) in congenital amegakaryocytic thrombocytopenia (CAMT). Hum Genet. 2000; 107(3):225-33. DOI: 10.1007/s004390000357. View

Ballmaier M, Germeshausen M, Schulze H, Cherkaoui K, Lang S, Gaudig A . c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood. 2001; 97(1):139-46. DOI: 10.1182/blood.v97.1.139. View

Levin J, Cocault L, Demerens C, Challier C, Pauchard M, Caen J . Thrombocytopenic c-mpl(-/-) mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response. Blood. 2001; 98(4):1019-27. DOI: 10.1182/blood.v98.4.1019. View

Ballmaier M, Germeshausen M, Krukemeier S, Welte K . Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia. Ann N Y Acad Sci. 2003; 996:17-25. DOI: 10.1111/j.1749-6632.2003.tb03228.x. View

Carpinelli M, Hilton D, Metcalf D, Antonchuk J, Hyland C, Mifsud S . Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc Natl Acad Sci U S A. 2004; 101(17):6553-8. PMC: 404083. DOI: 10.1073/pnas.0401496101. View

Ding J, Komatsu H, Wakita A, Kato-Uranishi M, Ito M, Satoh A . Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood. 2004; 103(11):4198-200. DOI: 10.1182/blood-2003-10-3471. View

10.

Berk P, Goldberg J, DONOVAN P, Fruchtman S, BERLIN N, WASSERMAN L . Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol. 1986; 23(2):132-43. View

11.

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

12.

Pear W, Nolan G, Scott M, Baltimore D . Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A. 1993; 90(18):8392-6. PMC: 47362. DOI: 10.1073/pnas.90.18.8392. View

13.

Alexander W, Roberts A, Nicola N, Li R, Metcalf D . Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood. 1996; 87(6):2162-70. View

14.

Broxmeyer H, Luoh S, Cooper S, Peng J, BURSTEIN S, Moore M . Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Blood. 1996; 88(3):803-8. View

15.

Cheng L, Du C, Murray D, Tong X, Zhang Y, Chen B . A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells. Gene Ther. 1998; 4(10):1013-22. DOI: 10.1038/sj.gt.3300507. View

16.

Wiestner A, Schlemper R, van der Maas A, Skoda R . An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet. 1998; 18(1):49-52. DOI: 10.1038/ng0198-49. View

17.

Moliterno A, HANKINS W, Spivak J . Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med. 1998; 338(9):572-80. DOI: 10.1056/NEJM199802263380903. View

18.

Kondo T, Okabe M, Sanada M, Kurosawa M, Suzuki S, Kobayashi M . Familial essential thrombocythemia associated with one-base deletion in the 5'-untranslated region of the thrombopoietin gene. Blood. 1998; 92(4):1091-6. View

19.

Kaushansky K . Thrombopoietin. N Engl J Med. 1998; 339(11):746-54. DOI: 10.1056/NEJM199809103391107. View

20.

Harrison C, Gale R, Machin S, Linch D . A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications. Blood. 1999; 93(2):417-24. View